* 181 (13%) respondents reported testing positive for SARS-CoV-2
* Of those who reported testing positive, 52% reported no known prior COVID-19 infection
* 1,435 (99.4%) of respondents reported at least one COVID-19 vaccine dose
* 49 (27%) of the respondents who tested positive received antiviral medications
* 70% of respondents reported not wearing a mask; the event coincided with a period of low COVID-19 Community Levels, where masking is not recommended in CDC guidance
* 181 (13%) respondents reported testing positive for SARS-CoV-2
* Of those who reported testing positive, 52% reported no known prior COVID-19 infection
* 1,435 (99.4%) of respondents reported at least one COVID-19 vaccine dose
* 49 (27%) of the respondents who tested positive received antiviral medications
* 70% of respondents reported not wearing a mask; the event coincided with a period of low COVID-19 Community Levels, where masking is not recommended in CDC guidance
* None were hospitalized